Clinical Trial Update: Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effects of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: Medical University of Vienna | Conditions: Cirrhosis, Ascites | Phase 4 | Status: COMPLETED